Skip to main content
logo
Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · Real-Time Price · USD
1.340
+0.030 (2.29%)
At close: Jul 29, 2026, 4:00 PM EDT
1.355
+0.015 (1.12%)
Pre-market: Jul 30, 2026, 6:40 AM EDT

Alzamend Neuro Ratios and Metrics

Millions USD. Fiscal year is May - Apr.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Market Cap
65555397
Market Cap Growth
-25.11%4.89%-5.44%-90.78%-45.53%-
Enterprise Value
5.714.140.684.8247.9183.33
Last Close Price
1.341.145.9463.99738.811377.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
PB Ratio
7.786.621.17-1.8917.427.29
P/TBV Ratio
6.105.190.68-17.526.81

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Debt / Equity Ratio
-00-0.1200
Net Debt / Equity Ratio
-0.97-0.97-0.990.03-1.69-1.05
Net Debt / EBITDA Ratio
0.080.080.890.010.351.14
Net Debt / FCF Ratio
0.090.090.570.010.582.09
Quick Ratio
0.530.536.220.121.7912.07
Current Ratio
1.311.316.580.142.0312.37
Return on Equity (ROE)
-343.52%-373.18%-657.17%-4408.31%-181.47%-160.92%
Return on Assets (ROA)
-244.51%-262.39%-171.81%-303.57%-145.56%-141.37%
Return on Invested Capital (ROIC)
-2559.28%-2367.91%-996.34%-3568.90%-16273.90%-4721.13%
Return on Capital Employed (ROCE)
-343.30%-372.94%-654.54%-4403.83%-181.38%-160.36%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24 Apr '23 Apr '22
Buyback Yield / Dilution
-640.27%-640.27%-507.76%-2.68%-9.45%-22.64%
Total Shareholder Return
-640.27%-640.27%-507.76%-2.68%-9.45%-22.64%
SEC Filings: 10-K · 10-Q